| Year |
Citation |
Score |
| 2023 |
Marsh IR, Li C, Grudzinski J, Jeffery J, Longhurst C, Adam DP, Hernandez R, Weichert JP, Harari PM, Bednarz BP. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry. Cancer Biotherapy & Radiopharmaceuticals. PMID 37022739 DOI: 10.1089/cbr.2022.0084 |
0.43 |
|
| 2023 |
Pinchuk AN, Rampy MA, Longino MA, Durkee BY, Counsell RE, Weichert JP. Effect of Polar Head Group Modifications on the Tumor Retention of Phospholipid Ether Analogs: Role of the Quaternary Nitrogen. Pharmaceutics. 15. PMID 36678801 DOI: 10.3390/pharmaceutics15010171 |
0.372 |
|
| 2022 |
Zhang RR, Choi C, Brunnquell CL, Hernandez R, Pinchuk AN, Grudzinski JG, Clark PA, McMillan AB, Audhya A, Jeffrey J, Kuo JS, Weichert JP. Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs. Investigative Radiology. 57: 655-663. PMID 36069439 DOI: 10.1097/RLI.0000000000000893 |
0.404 |
|
| 2021 |
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, ... ... Weichert J, et al. Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science Translational Medicine. 13. PMID 34261797 DOI: 10.1126/scitranslmed.abb3631 |
0.389 |
|
| 2021 |
Carlson PM, Mohan M, Patel RB, Birstler J, Nettenstrom L, Sheerar D, Fox K, Rodriguez M, Hoefges A, Hernandez R, Zahm C, Kim K, McNeel DG, Weichert J, Morris ZS, et al. Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 34261667 DOI: 10.4049/jimmunol.2000656 |
0.322 |
|
| 2021 |
Clark PA, Sriramaneni RN, Bates AM, Jin WJ, Jagodinsky JC, Hernandez R, Le T, Jeffery JJ, Marsh IR, Grudzinski JJ, Aluicio-Sarduy E, Barnhart TE, Anderson BR, Chakravarty I, Arthur IS, ... ... Weichert JP, et al. Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain. Radiation Research. PMID 33826741 DOI: 10.1667/RADE-20-00237.1 |
0.323 |
|
| 2020 |
Sosa GA, Bates AM, Patel R, Hernandez R, Grudzinski JJ, Marsh I, Bednarz B, Pieper A, Nystuen E, Emma S, Sumiec EG, Weichert JP, Morris ZS. Abstract 903: In vivo efficacy of bempegaldesleukin, immune checkpoint inhibition, and targeted radionuclide therapy in immunocompetent murine model of head and neck cancer Immunology. 80: 903-903. DOI: 10.1158/1538-7445.Am2020-903 |
0.498 |
|
| 2020 |
Jagodinsky JC, Arthur IS, Castillo JS, Chakravarty I, Zangl LM, Brown RJ, Patel RB, Jin WJ, Carlson PM, Hernandez R, Grudzinski JJ, Marsh IR, Weichert JP, Bednarz BP, Morris ZS. Abstract 477: Comparing type 1 interferon activation in tumor cells following external beam radiotherapy versus targeted radionuclide therapy Tumor Biology. DOI: 10.1158/1538-7445.Am2020-477 |
0.344 |
|
| 2019 |
Hernandez R, Grudzinski JJ, Aluicio-Sarduy E, Massey CF, Pinchuk AN, Bitton AN, Patel R, Zhang R, Kumar AV, Iyer G, Engle JW, Weichert JP. Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31862799 DOI: 10.2967/Jnumed.119.236265 |
0.494 |
|
| 2019 |
Hall LT, Titz B, Baidya N, van der Kolk AG, Robins HI, Otto M, Perlman SB, Weichert JP, Kuo JS. [I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31183841 DOI: 10.1007/S11307-019-01362-1 |
0.462 |
|
| 2019 |
Zhang RR, Grudzinski JJ, Mehta TI, Burnette RR, Hernandez R, Clark PA, Lubin JA, Pinchuk AN, Jeffery J, Longino M, Kuo JS, Weichert JP. In Silico Docking of Alkylphosphocholine Analogs to Human Serum AlbuminPredict Partitioning and Pharmacokinetics. Molecular Pharmaceutics. PMID 31082240 DOI: 10.1021/Acs.Molpharmaceut.8B01301 |
0.303 |
|
| 2019 |
Grudzinski JJ, Hernandez R, Marsh I, Patel R, Aluicio-Sarduy E, Engle J, Morris Z, Bednarz B, Weichert JP. Preclinical Characterization of Y-NM600 in a variety of murine and human cancer tumor models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30954941 DOI: 10.2967/Jnumed.118.224808 |
0.553 |
|
| 2019 |
Marsh IR, Grudzinski JJ, Baiu DC, Besemer AE, Hernandez R, Jeffery JJ, Weichert JP, Otto M, Bednarz BP. Preclinical pharmacokinetics and dosimetry studies of [I/I]-CLR1404 for treatment of pediatric solid tumors in murine xenograft models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30926646 DOI: 10.2967/Jnumed.118.225409 |
0.51 |
|
| 2019 |
Hernandez R, Walker KL, Grudzinski JJ, Aluicio-Sarduy E, Patel R, Zahm CD, Pinchuk AN, Massey CF, Bitton AN, Brown RJ, Sondel PM, Morris ZS, Engle JW, Capitini CM, Weichert JP. Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma. Communications Biology. 2: 79. PMID 30820474 DOI: 10.1038/s42003-019-0327-4 |
0.357 |
|
| 2018 |
Besemer AE, Grudzinski JJ, Weichert JP, Hall LT, Bednarz BP. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in Triple-Negative Breast Cancer Patient. Cancer Biotherapy & Radiopharmaceuticals. PMID 30351218 DOI: 10.1089/Cbr.2018.2568 |
0.351 |
|
| 2018 |
Elsaid MY, Shahi A, Wang AR, Baiu DC, Li C, Werner LR, Singhal S, Hall LT, Weichert JP, Armstrong EA, Bednarz BP, Harari PM, Iyer G, Otto M. Enhanced Radiosensitivity in Solid Tumors using a Tumor-Selective Alkyl Phosphocholine Analog. Molecular Cancer Therapeutics. PMID 30108133 DOI: 10.1158/1535-7163.Mct-17-0897 |
0.471 |
|
| 2018 |
Bednarz B, Grudzinski J, Marsh I, Besemer A, Baiu D, Weichert J, Otto M. Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Physics. 114: 450-459. PMID 29481536 DOI: 10.1097/Hp.0000000000000789 |
0.383 |
|
| 2018 |
Li C, Mylin JM, Weichert JP, Jeffery JJ, Weichmann AM, Nickel KP, Abel LJ, Hernandez R, Grudzinski JJ, Marsh IR, Bednarz BP, Piaskowski SM, Harari PM. Abstract 851: Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer murine xenograft models Cancer Research. 78: 851-851. DOI: 10.1158/1538-7445.Am2018-851 |
0.485 |
|
| 2018 |
Shahi A, Elsaid MY, Baiu DC, Armstrong EA, Weichert JP, Harari PM, Otto M. Abstract A111: The alkyl phosphocholine analog CLR1404 delays radiation-induced dsDNA damage repair in pediatric and adult solid tumors Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A111 |
0.435 |
|
| 2017 |
Olson BM, Gamat M, Seliski J, Sawicki T, Jeffery J, Ellis L, Drake CG, Weichert J, McNeel DG. Prostate cancer cells express more androgen receptor (AR) following androgen deprivation, improving recognition by AR-specific T cells. Cancer Immunology Research. PMID 29051161 DOI: 10.1158/2326-6066.Cir-16-0390 |
0.309 |
|
| 2017 |
Hall LT, Titz B, Robins HI, Bednarz BP, Perlman SB, Weichert JP, Kuo JS. PET/CT imaging of the diapeutic alkylphosphocholine analog (124)I-CLR1404 in high and low-grade brain tumors. American Journal of Nuclear Medicine and Molecular Imaging. 7: 157-166. PMID 28913154 |
0.392 |
|
| 2017 |
Baiu DC, Marsh IR, Boruch AE, Shahi A, Bhattacharya S, Jeffery JJ, Zhao Q, Hall L, Weichert JP, Bednarz B, Otto M. Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28747518 DOI: 10.2967/Jnumed.117.193748 |
0.506 |
|
| 2017 |
Besemer AE, Titz B, Grudzinski JJ, Weichert JP, Kuo JS, Robins HI, Hall LT, Bednarz BP. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404. Physics in Medicine and Biology. 62: 6008-6025. PMID 28682793 DOI: 10.1088/1361-6560/Aa716D |
0.482 |
|
| 2017 |
Tummers WS, Warram JM, Tipirneni KE, Fengler J, Jacobs P, Shankar L, Henderson L, Ballard B, Pogue BW, Weichert JP, Bouvet M, Sorger J, Contag CH, Frangioni JV, Tweedle MF, et al. Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection. Cancer Research. PMID 28428283 DOI: 10.1158/0008-5472.Can-16-3217 |
0.365 |
|
| 2017 |
Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, Eliceiri KW, Kuo JS, Weichert JP. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nature Reviews. Clinical Oncology. PMID 28094261 DOI: 10.1038/Nrclinonc.2016.212 |
0.349 |
|
| 2016 |
Kuo JS, Zhang RR, Pinchuk AN, Jeffrey J, Clark PA, Weichert JP. 364 Creation of a Dual-Labeled Cancer-Targeting Alkylphosphocholine Analog for Dual Modality Quantitative Positron Emission Tomography and Intraoperative Tumor Visualization. Neurosurgery. 63: 208. PMID 28175546 DOI: 10.1227/01.neu.0000489852.78064.fb |
0.331 |
|
| 2016 |
Brunnquell C, Zhang R, Pinchuk A, Weichert J. WE-H-207A-08: Characterization of a Broad-Spectrum Cancer Targeted MRI Contrast Agent. Medical Physics. 43: 3847. PMID 28047779 DOI: 10.1118/1.4958013 |
0.389 |
|
| 2016 |
Zhang RR, Swanson KI, Hall LT, Weichert JP, Kuo JS. Diapeutic cancer-targeting alkylphosphocholine analogs may advance management of brain malignancies. Cns Oncology. PMID 27616199 DOI: 10.2217/Cns-2016-0017 |
0.367 |
|
| 2016 |
Clark PA, Al-Ahmad AJ, Qian T, Zhang RR, Wilson HK, Weichert JP, Palecek SP, Kuo JS, Shusta EV. Analysis of Cancer-targeting Alkylphosphocholine Analog Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Molecular Pharmaceutics. PMID 27421304 DOI: 10.1021/Acs.Molpharmaceut.6B00441 |
0.344 |
|
| 2016 |
Kuo JS, Zhang RR, Pinchuk AN, Jeffrey J, Clark PA, Weichert JP. 364 Creation of a Dual-Labeled Cancer-Targeting Alkylphosphocholine Analog for Dual Modality Quantitative Positron Emission Tomography and Intraoperative Tumor Visualization. Neurosurgery. 63: 208. PMID 27399561 DOI: 10.1227/01.Neu.0000489852.78064.Fb |
0.446 |
|
| 2016 |
Marsh I, Otto M, Weichert J, Baiu D, Bednarz B. SU-G-TeP3-08: Pre-Clinical Radionuclide Therapy Dosimetry in Several Pediatric Cancer Xenografts Medical Physics. 43: 3675-3675. DOI: 10.1118/1.4957088 |
0.443 |
|
| 2015 |
Marino R, Baiu DC, Bhattacharya S, Titz B, Hebron E, Menapace BD, Singhal S, Eickhoff JC, Asimakopoulos F, Weichert JP, Otto M. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma. American Journal of Cancer Research. 5: 3422-35. PMID 26807322 |
0.407 |
|
| 2015 |
Lubner SJ, Mullvain J, Perlman S, Pishvaian M, Mortimer J, Oliver K, Heideman J, Hall L, Weichert J, Liu G. A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of (131)I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies. Cancer Investigation. 1-7. PMID 26536061 DOI: 10.3109/07357907.2015.1081691 |
0.473 |
|
| 2015 |
Morris ZS, Weichert JP, Saker J, Armstrong EA, Besemer A, Bednarz B, Kimple RJ, Harari PM. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 504-9. PMID 26123834 DOI: 10.1016/J.Radonc.2015.06.015 |
0.407 |
|
| 2015 |
Swanson KI, Clark PA, Zhang RR, Kandela IK, Farhoud M, Weichert JP, Kuo JS. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery. 76: 115-23; discussion 1. PMID 25549194 DOI: 10.1227/Neu.0000000000000622 |
0.389 |
|
| 2015 |
Clark P, Al-Ahmad A, Qian T, Zhang R, Jeffery J, Wilson H, Palecek S, Weichert J, Shusta E, Kuo J. DDEL-05DIFFERENTIAL BLOOD-BRAIN BARRIER (BBB) PERMEABILITY OF ALKYLPHOSPHOCHOLINE (APC) ANALOGS ANALYZED USING AN IN VITRO PLURIPOTENT STEM CELL-DERIVED BRAIN MICROVASCULAR ENDOTHELIAL CELL SYSTEM Neuro-Oncology. 17: v74.1-v74. DOI: 10.1093/Neuonc/Nov212.05 |
0.333 |
|
| 2014 |
Korb ML, Warram JM, Grudzinski J, Weichert J, Jeffery J, Rosenthal EL. Breast cancer imaging using the near-infrared fluorescent agent, CLR1502. Molecular Imaging. 13. PMID 25743270 DOI: 10.2310/7290.2014.00040 |
0.421 |
|
| 2014 |
Grudzinski JJ, Titz B, Kozak K, Clarke W, Allen E, Trembath L, Stabin M, Marshall J, Cho SY, Wong TZ, Mortimer J, Weichert JP. A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety. Plos One. 9: e111652. PMID 25402488 DOI: 10.1371/Journal.Pone.0111652 |
0.362 |
|
| 2014 |
Deming DA, Maher ME, Leystra AA, Grudzinski JP, Clipson L, Albrecht DM, Washington MK, Matkowskyj KA, Hall LT, Lubner SJ, Weichert JP, Halberg RB. Phospholipid ether analogs for the detection of colorectal tumors. Plos One. 9: e109668. PMID 25286226 DOI: 10.1371/Journal.Pone.0109668 |
0.488 |
|
| 2014 |
Weichert JP, Clark PA, Kandela IK, Vaccaro AM, Clarke W, Longino MA, Pinchuk AN, Farhoud M, Swanson KI, Floberg JM, Grudzinski J, Titz B, Traynor AM, Chen HE, Hall LT, et al. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy. Science Translational Medicine. 6: 240ra75. PMID 24920661 DOI: 10.1126/Scitranslmed.3007646 |
0.528 |
|
| 2014 |
Deming DA, Leystra AA, Nettekoven L, Sievers C, Miller D, Middlebrooks M, Clipson L, Albrecht D, Bacher J, Washington MK, Weichert J, Halberg RB. PIK3CA and APC mutations are synergistic in the development of intestinal cancers. Oncogene. 33: 2245-54. PMID 23708654 DOI: 10.1038/Onc.2013.167 |
0.363 |
|
| 2014 |
Deming DA, Maher M, Leystra AA, Grudzinski J, Clipson L, Albrecht D, Washington MK, Matkowskyj K, Pazoles CJ, Hall LT, Lubner SJ, Weichert J, Halberg RB. Phospholipid ether analogs for the detection of colorectal cancers. Journal of Clinical Oncology. 32: 486-486. DOI: 10.1200/Jco.2014.32.3_Suppl.486 |
0.488 |
|
| 2014 |
Lubner SJ, Mullvain JA, Hall LT, Pishavian M, Mortimer JE, Oliver K, Heideman J, Weichert J, Liu G. A phase 1 study of phospholipid ether [131I]-CLR1404 in patients with advanced solid tumors. Journal of Clinical Oncology. 32: 2557-2557. DOI: 10.1200/Jco.2014.32.15_Suppl.2557 |
0.45 |
|
| 2014 |
Pickhardt PJ, Hall LT, Lee M, Longino M, Pinchuk A, Banash M, Grudzinski J, Titz B, Jaskowiak C, Kuo JS, Weichert J. A novel “diapeutic” molecular imaging agent for combined oncologic diagnosis and therapy in a broad spectrum of human cancers: Preliminary clinical experience with CLR1404. Journal of Clinical Oncology. 32: 11000-11000. DOI: 10.1200/Jco.2014.32.15_Suppl.11000 |
0.349 |
|
| 2014 |
Kuo JS, Weichert JP, Clark PA, Kandela IK, Vacaro A, Clark W, Longino M, Pinchuk A, Farhoud M, Swanson KI, Floberg J, Traynor A, Hall LT, Pazoles C. NOVEL ALKYLPHOSPHOCHOLINE ANALOGS FOR BROAD SPECTRUM CANCER IMAGING AND THERAPY Neuro-Oncology. 16: iii10-iii11. DOI: 10.1093/Neuonc/Nou206.37 |
0.457 |
|
| 2013 |
Titz B, Grudzinski JJ, Barbee DL, Weichert JP. TU-E-141-08: Dosimetric Impact of Partial Volume Correction On PET-Based Targeted Radionuclide Therapy Planning. Medical Physics. 40: 448. PMID 28518796 DOI: 10.1118/1.4815436 |
0.303 |
|
| 2013 |
Besemer A, Grudzinski J, Titz B, Wickre P, Hall L, Weichert J, Bednarz B. SU-F-500-01: Towards Personalized Dosimetry Using Diapeutic Radiopharmaceuticals. Medical Physics. 40: 382. PMID 28518396 DOI: 10.1118/1.4815191 |
0.314 |
|
| 2013 |
Deming DA, Leystra AA, Farhoud M, Nettekoven L, Clipson L, Albrecht D, Washington MK, Sullivan R, Weichert JP, Halberg RB. mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers. Plos One. 8: e60709. PMID 23593290 DOI: 10.1371/Journal.Pone.0060709 |
0.484 |
|
| 2013 |
Saker J, Armstrong E, Bednarz B, Farhoud M, Besemer A, Weichert J, Harari P. Abstract 4536: Combination external beam and internal radiation via 131I-CLR1404 in the treatment of head and neck squamous cell carcinoma xenografts. Cancer Research. 73: 4536-4536. DOI: 10.1158/1538-7445.Am2013-4536 |
0.438 |
|
| 2013 |
Deming D, Leystra A, Nettekoven L, Kohns C, Clipson L, Albrecht D, Bacher J, Washington MK, Pazoles C, Weichert J, Halberg R. Abstract 2738:PIK3CAandAPCmutations are synergistic in the development of intestinal cancers. Cancer Research. 73: 2738-2738. DOI: 10.1158/1538-7445.Am2013-2738 |
0.457 |
|
| 2012 |
Floberg JM, Mistretta CA, Weichert JP, Hall LT, Holden JE, Christian BT. Improved kinetic analysis of dynamic PET data with optimized HYPR-LR. Medical Physics. 39: 3319-31. PMID 22755714 DOI: 10.1118/1.4718669 |
0.311 |
|
| 2012 |
Leystra AA, Deming DA, Zahm CD, Farhoud M, Olson TJ, Hadac JN, Nettekoven LA, Albrecht DM, Clipson L, Sullivan R, Washington MK, Torrealba JR, Weichert JP, Halberg RB. Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Research. 72: 2931-6. PMID 22525701 DOI: 10.1158/0008-5472.Can-11-4097 |
0.453 |
|
| 2012 |
Grudzinski JJ, Floberg JM, Mudd SR, Jeffery JJ, Peterson ET, Nomura A, Burnette RR, Tomé WA, Weichert JP, Jeraj R. Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT. Physics in Medicine and Biology. 57: 1641-57. PMID 22398155 DOI: 10.1088/0031-9155/57/6/1641 |
0.743 |
|
| 2012 |
Cho H, Indig GL, Weichert J, Shin HC, Kwon GS. In vivo cancer imaging by poly(ethylene glycol)-b-poly(ɛ-caprolactone) micelles containing a near-infrared probe. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 228-36. PMID 21704593 DOI: 10.1016/J.Nano.2011.06.009 |
0.401 |
|
| 2012 |
Pazoles C, Vaccaro A, Kandela I, Pinchuk A, Farhoud M, Longino M, Weichert J. Abstract 5740:124I-CLR1404 and131I-CLR1404: Broad spectrum diapeutic agents for cancer cell-targeted PET imaging and molecular radiotherapy Cancer Research. 72: 5740-5740. DOI: 10.1158/1538-7445.Am2012-5740 |
0.505 |
|
| 2012 |
Pazoles C, Vaccaro A, Kandela I, Pinchuk A, Farhoud M, Longino M, Weichert J. Abstract 3831: 131I-CLR1404 and CLR1404: Broad spectrum, cancer-targeted molecular radio- and chemotherapeutic phospholipid ether analogs Cancer Research. 72: 3831-3831. DOI: 10.1158/1538-7445.Am2012-3831 |
0.436 |
|
| 2012 |
Clark PA, Chen H, Mohamed M, Kandela IK, Longino MA, Pinchuk A, Weichert JP, Kuo JS. Abstract 3495: The novel phospholipid ether analog CLR1404 decreases glioblastoma stem cell proliferation, suppresses GBM growth, and improves survival Cancer Research. 72: 3495-3495. DOI: 10.1158/1538-7445.Am2012-3495 |
0.394 |
|
| 2012 |
Deming DA, Leystra AA, Christopher ZD, Farhoud M, Olson TJP, Hadac JN, Nettekoven LA, Albrecht DM, Clipson L, Sullivan R, Washington MK, Torrealba JR, Weichert JP, Halberg RB. Abstract 1341: Mice expressing activated PI3K develop advanced colon cancer Cancer Research. 72: 1341-1341. DOI: 10.1158/1538-7445.Am2012-1341 |
0.463 |
|
| 2011 |
Hafeez BB, Zhong W, Weichert J, Dreckschmidt NE, Jamal MS, Verma AK. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma. Cancer Research. 71: 2318-27. PMID 21406403 DOI: 10.1158/0008-5472.Can-10-4170 |
0.35 |
|
| 2011 |
Hafeez BB, Zhong W, Weichert J, Jamal MS, Verma AK. Abstract 1614: Genetic loss of PKC epsilon inhibits development and metastasis of prostate cancer in transgenic adenocarcinoma of mouse prostate model Cancer Research. 71: 1614-1614. DOI: 10.1158/1538-7445.Am2011-1614 |
0.372 |
|
| 2010 |
Grudzinski JJ, Burnette RR, Weichert JP, Jeraj R. Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape. Cancer Biotherapy & Radiopharmaceuticals. 25: 417-26. PMID 20735205 DOI: 10.1089/Cbr.2009.0754 |
0.426 |
|
| 2010 |
Mudd SR, Trubetskoy VS, Blokhin AV, Weichert JP, Wolff JA. Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery system. Bioconjugate Chemistry. 21: 1183-9. PMID 20552976 DOI: 10.1021/Bc900558Z |
0.736 |
|
| 2010 |
Grudzinski JJ, Yoriyaz H, DeLuca PM, Weichert JP. Patient specific treatment planning for systemically administered radiopharmaceuticals using PET/CT and Monte Carlo simulation Applied Radiation and Isotopes. 68: 59-65. PMID 19879154 DOI: 10.1016/J.Apradiso.2009.09.070 |
0.404 |
|
| 2010 |
Durkee BY, Weichert JP, Halberg RB. Small animal micro-CT colonography. Methods (San Diego, Calif.). 50: 36-41. PMID 19651214 DOI: 10.1016/J.Ymeth.2009.07.008 |
0.784 |
|
| 2009 |
Durkee BY, Shinki K, Newton MA, Iverson CE, Weichert JP, Dove WF, Halberg RB. Longitudinal assessment of colonic tumor fate in mice by computed tomography and optical colonoscopy. Academic Radiology. 16: 1475-82. PMID 19896065 DOI: 10.1016/J.Acra.2009.07.023 |
0.775 |
|
| 2009 |
Grudzinski J, Bowen S, Tome W, Weichert J, Jeraj R. SU-FF-T-458: Complementing Targeted Radionuclide Therapy with External Beam Radiotherapy: Planning Study Medical Physics. 36: 2628-2628. DOI: 10.1118/1.3181940 |
0.307 |
|
| 2009 |
Christensen MB, Halberg RB, Schutten MM, Weichert JP. MicroPET/CT colonoscopy in long-lived min mouse using NM404 Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7262. DOI: 10.1117/12.811722 |
0.458 |
|
| 2008 |
Durkee BY, Mudd SR, Roen CN, Clipson L, Newton MA, Weichert JP, Pickhardt PJ, Halberg RB. Reproducibility of tumor volume measurement at microCT colonography in living mice. Academic Radiology. 15: 334-41. PMID 18280931 DOI: 10.1016/J.Acra.2007.10.005 |
0.746 |
|
| 2008 |
Grudzinski J, Weichert J, Jeraj R. SU-GG-I-139: Improving the Efficacy of a Radionuclide Targeting Agent by Simulating Its Pharmacokinetics Medical Physics. 35: 2674-2674. DOI: 10.1118/1.2961537 |
0.475 |
|
| 2008 |
Nwankwo J, McCord JH, Wentworth M, Weichert J, Weber SM. M1843 Decreased PLD2 Expression Correlates with NM404 Retention in Human Colorectal Cancer Xenografts Gastroenterology. 134: A-874. DOI: 10.1016/S0016-5085(08)64098-6 |
0.31 |
|
| 2007 |
Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichert J, Haag JD, Chen KS, Waller JL, Gould MN, Dove WF. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 104: 4036-41. PMID 17360473 DOI: 10.1073/Pnas.0611690104 |
0.421 |
|
| 2007 |
Durkee B, Amos-Landgraf J, Ton G, Longino M, Halberg R, Dove W, Weichert J. CMR 2007: 4.01: Dual-modality virtual colonoscopy of colon cancer progression with 124I-NM404 Contrast Media & Molecular Imaging. 2: 282-283. DOI: 10.1002/Cmmi.173 |
0.741 |
|
| 2006 |
Pinchuk AN, Rampy MA, Longino MA, Skinner RW, Gross MD, Weichert JP, Counsell RE. Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues. Journal of Medicinal Chemistry. 49: 2155-65. PMID 16570911 DOI: 10.1021/jm050252g |
0.412 |
|
| 2006 |
Weichert JP, Longino MA, Perlman S, Pinchuk A, Schiller J. CMR 2005: 3.08: Preliminary imaging results with NM404 in lung cancer patients Contrast Media & Molecular Imaging. 1: 60-61. DOI: 10.1002/Cmmi.21 |
0.311 |
|
| 2005 |
Ton GN, Weichert JP, Longino MA, Fine JP, Kwon GS. Methoxypoly(ethylene glycol)-conjugated carboxypeptidase A for solid tumor targeting: part II: pharmacokinetics and biodistribution in normal and tumor-bearing rodents. Journal of Controlled Release : Official Journal of the Controlled Release Society. 104: 155-66. PMID 15866342 DOI: 10.1016/J.Jconrel.2005.01.015 |
0.493 |
|
| 2005 |
Pickhardt PJ, Halberg RB, Taylor AJ, Durkee BY, Fine J, Lee FT, Weichert JP. Microcomputed tomography colonography for polyp detection in an in vivo mouse tumor model. Proceedings of the National Academy of Sciences of the United States of America. 102: 3419-22. PMID 15728368 DOI: 10.1073/Pnas.0409915102 |
0.797 |
|
| 2005 |
Weichert J, Moser A, Weber S, Qi C, Longino M. Radioiodinated NM404-a Universal Tumor Imaging Agent? Academic Radiology. 12: S58-S59. DOI: 10.1016/J.Acra.2005.03.017 |
0.455 |
|
| 2005 |
Weichert J, Moser A, Durkee B, Bjorling D, Longino M, Lee F. Virtual MicroCT Angiography with BP20 in Live Mice Academic Radiology. 12: S48-S49. DOI: 10.1016/J.Acra.2005.03.005 |
0.732 |
|
| 2004 |
Weber SM, Peterson KA, Durkee B, Qi C, Longino M, Warner T, Lee FT, Weichert JP. Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: Accuracy is dependent on adequate contrast enhancement Journal of Surgical Research. 119: 41-45. PMID 15126080 DOI: 10.1016/S0022-4804(03)00357-3 |
0.785 |
|
| 2002 |
Doerr-Stevens JK, Bakan DA, Lee FT, Chosy SG, Markhardt BK, Bonneville AK, Burrascano C, Delaney C, Longino MA, Greener Y, Weichert JP. Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride (DHOG-LE) for contrast-enhanced CT. Academic Radiology. 9: S200-4. PMID 12019869 DOI: 10.1016/S1076-6332(03)80436-1 |
0.366 |
|
| 2002 |
Bakan DA, Lee FT, Weichert JP, Longino MA, Counsell RE. Hepatobiliary imaging using a novel hepatocyte-selective CT contrast agent. Academic Radiology. 9: S194-9. PMID 12019866 DOI: 10.1016/S1076-6332(03)80435-X |
0.342 |
|
| 2002 |
Wisner ER, Weichert JP, Longino MA, Counsell RE, Weisbrode SE. A surface-modified chylomicron remnant-like emulsion for percutaneous computed tomography lymphography: synthesis and preliminary imaging findings. Investigative Radiology. 37: 232-9. PMID 11923646 DOI: 10.1097/00004424-200204000-00009 |
0.319 |
|
| 2001 |
Bakan DA, Doerr-Stevens JK, Weichert JP, Longino MA, Lee FT, Counsell RE. Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride for contrast-enhanced computed tomography. American Journal of Therapeutics. 8: 359-65. PMID 11550077 DOI: 10.1097/00045391-200109000-00009 |
0.306 |
|
| 2000 |
Weichert JP, Lee FT, Chosy SG, Longino MA, Kuhlman JE, Heisey DM, Leverson GE. Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits. Radiology. 216: 865-71. PMID 10966724 DOI: 10.1148/Radiology.216.3.R00Se43865 |
0.408 |
|
| 2000 |
Bakan DA, Weichert JP, Longino MA, Counsell RE. Polyiodinated triglyceride lipid emulsions for use as hepatoselective contrast agents in CT: effects of physicochemical properties on biodistribution and imaging profiles. Investigative Radiology. 35: 158-69. PMID 10719825 DOI: 10.1097/00004424-200003000-00002 |
0.334 |
|
| 1996 |
Lee FT, Mack E, Bakan DA, Weichert JP, Rappe AH, Chosy SG. Iodinated triglyceride--enhanced three-dimensional biliary imaging with helical computed tomography scanning in dogs. Academic Radiology. 3: S449-51. PMID 8796626 DOI: 10.1016/S1076-6332(96)80613-1 |
0.323 |
|
| 1996 |
Weichert JP, Lee FT, Longino MA, Bakan DA, Spigarelli MG, Francis IR, Counsell RE. Computed tomography scanning of hepatic tumors with polyiodinated triglycerides. Academic Radiology. 3: S229-31. PMID 8796569 DOI: 10.1016/S1076-6332(96)80543-5 |
0.323 |
|
| 1995 |
Rampy MA, Pinchuk AN, Weichert JP, Skinner RW, Fisher SJ, Wahl RL, Gross MD, Counsell RE. Synthesis and biological evaluation of radioiodinated phospholipid ether stereoisomers. Journal of Medicinal Chemistry. 38: 3156-62. PMID 7636878 DOI: 10.1021/Jm00016A019 |
0.305 |
|
| 1995 |
Weichert JP, Longino M, Bakan D, Spigarelli M, Francis I, Counsell R. CT imaging of morris hepatoma with liver-specific polyiodinated triglycerides Academic Radiology. 2: 1140. DOI: 10.1016/S1076-6332(05)80553-7 |
0.341 |
|
| 1987 |
WEICHERT JP, GROZIAK MP, LONGINO MA, SCHWENDNER SW, COUNSELL RE. ChemInform Abstract: Potential Tumor- or Organ-Imaging Agents. Part 27. Polyiodinated 1,3-Disubstituted and 1,2,3-Trisubstituted Triacylglycerols. Cheminform. 18. DOI: 10.1002/chin.198718129 |
0.318 |
|
| 1986 |
Weichert JP, Groziak MP, Longino MA, Schwendner SW, Counsell RE. Potential tumor- or organ-imaging agents. 27. Polyiodinated 1,3-disubstituted and 1,2,3-trisubstituted triacylglycerols. Journal of Medicinal Chemistry. 29: 2457-65. PMID 3783605 DOI: 10.1021/Jm00162A007 |
0.356 |
|
| 1986 |
Weichert JP, Longino MA, Schwendner SW, Counsell RE. Potential tumor- or organ-imaging agents. 26. Polyiodinated 2-substituted triacylglycerols as hepatographic agents. Journal of Medicinal Chemistry. 29: 1674-82. PMID 3746816 DOI: 10.1021/Jm00159A019 |
0.305 |
|
| 1984 |
Longino MA, Glazer GM, Weichert JP, Groziak MP, Schwendner SW, Counsell RE. Esters of iopanoic acid as liver-specific CT contrast agents: biodistribution and CT evaluation. Journal of Computer Assisted Tomography. 8: 1099-104. PMID 6501618 DOI: 10.1097/00004728-198412000-00010 |
0.374 |
|
| 1983 |
Glazer GM, Longino MA, Schwendner SW, Counsell RE, Weichert JP. Lipid soluble contrast agents for computed tomography of the liver: results with cholesteryl iopanoate. Journal of Computer Assisted Tomography. 7: 775-9. PMID 6886127 DOI: 10.1097/00004728-198310000-00004 |
0.381 |
|
| Show low-probability matches. |